Corona Remedies Ltd

CORONA

Company Profile

  • Business description

    Corona Remedies Ltd is a pharmaceutical formulation company engaged in developing, manufacturing, and marketing products in women's healthcare, cardio-diabetes, pain management, urology, and other therapeutic areas. The company offers products across the following therapeutic areas: women's health, cardio-diabetes, pain management, urology, and others/multispecialty pharmaceuticals (comprising VMN, gastrointestinal, and respiratory). The company operates in only one reportable business segment, i.e., pharmaceuticals. It generates a substantial portion of its revenue from operations in certain therapeutic areas in India, with the majority coming from women's healthcare.

  • Contact

    S. G. Highway, CORONA House
    C - Mondeal Business Park, Near Gurudwara
    Thaltej
    AhmedabadGJ380 059
    IND

    T: +91 7940233000

    https://www.coronaremedies.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - General

    Fiscal Year End

    31 March 2027

    Employees

    4,573

Stocks News & Analysis

stocks

Eli Lilly receives FDA approval to add another oral GLP-1 to market

Wide moat Eli Lilly receives FDA approval for obesity pill.
stocks

Our top ASX picks in every sector

These companies are our favourite choices for investors wanting to boost Aussie equity exposure.
stocks

Which of the 3 giant AI IPOs should you buy?

OpenAI, Anthropic, and Databricks are expected to go public this year at massive valuations.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,786.70113.00-1.27%
CAC 407,981.27164.332.10%
DAX 4023,298.89618.852.73%
Dow JONES (US)46,565.74224.230.48%
FTSE 10010,364.79188.341.85%
HKSE25,058.08235.95-0.93%
NASDAQ21,840.95250.321.16%
Nikkei 22552,731.941,007.74-1.88%
NZX 50 Index12,881.1755.300.43%
S&P 5006,575.3246.800.72%
S&P/ASX 2008,590.4094.60-1.09%
SSE Composite Index3,926.6421.91-0.55%

Market Movers